Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
07/25/2002 | US20020098582 Differentiated stem cells suitable for human therapy |
07/25/2002 | US20020098581 Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor |
07/25/2002 | US20020098580 MDM interacting protein and methods of use thereof |
07/25/2002 | US20020098579 Methods and compositions for poly-beta-1-4-N acetylglucosamine cell therapy system |
07/25/2002 | US20020098576 Recombinant sendai virus |
07/25/2002 | US20020098573 Generating preferential vector nucleotide sequences; obtain nucleotide sequences, incubate with preferential exogenous nucleotide sequences, ligate, recover nucleotide sequences |
07/25/2002 | US20020098572 Conditional replication and expression system |
07/25/2002 | US20020098570 Muskmelon (Cucumis melo) hydroperoxide lyase and uses thereof |
07/25/2002 | US20020098565 Polyhydroxyalkanoate synthase and gene encoding the same |
07/25/2002 | US20020098560 Nuclelotide sequences coding enzyme inhibitor for use in the treatment of blood sisorders |
07/25/2002 | US20020098559 Treating isolated pancreatic islet cells; obtain pancreatic cells, culture, cover cell in membrane, monitor cells |
07/25/2002 | US20020098551 From a hybrid cell formed from the fusion of two or more cells, each of which cell is engineered to express one component of the multimeric protein, as well as a method for screening for successful fusion of the cells |
07/25/2002 | US20020098550 Nucleotide sequences coding membrane protein for use in treatment and prevention of endotoxin shock, viral disease, immflammation and tumors |
07/25/2002 | US20020098544 Polypeptide for use in screening bactericides |
07/25/2002 | US20020098542 Novel forms of T cell costimulatory molecules and uses therefor |
07/25/2002 | US20020098540 Novel polypeptides, and nucleic acids encoding the same |
07/25/2002 | US20020098525 Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 |
07/25/2002 | US20020098521 Method and marker for the isolation of human multipotent hematopoietic stem cells |
07/25/2002 | US20020098507 Nucleotide sequences coding polypeptide for use in human diagnostics and therapeutics; for use as biosensors |
07/25/2002 | US20020098506 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/25/2002 | US20020098505 Nucleotide sequences coding polypeptide for use in human diagnostics, therapeutics; for use as biosensors |
07/25/2002 | US20020098486 Novel human transferase proteins and polynucleotides encoding the same |
07/25/2002 | US20020098477 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
07/25/2002 | US20020098475 Bovine immunodeficiency virus (BIV) based vectors |
07/25/2002 | US20020098470 Cryogenic stabilization of cells; obtain cells, inject with cryogenic agent, activate latent state, store cells |
07/25/2002 | US20020098469 Extracorporeal methods for enhancing antigen presentation and immune responsiveness |
07/25/2002 | US20020098223 Recombinant cells comprising retroviral vector |
07/25/2002 | US20020098201 Novel myxoma genes for immune modulation |
07/25/2002 | US20020098192 Polyalkylene oxide-modified single chain polypeptides |
07/25/2002 | US20020098177 17867, a novel human aminopeptidase |
07/25/2002 | US20020098176 Inhibition of tumor growth by a nematode anticoagulant protein |
07/25/2002 | US20020098167 Administration of stem cells with cytokines |
07/25/2002 | US20020098166 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
07/25/2002 | US20020098165 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin |
07/25/2002 | US20020096123 Integrated herd management system utilizing isolated populations of X-chromosome bearing and Y-chromosome bearing spermatozoa |
07/25/2002 | DE10104094C1 Increasing viral replication and yield in cell cultures, useful e.g. for detecting residual hepatitis A in inactivated products, by blocking activation of RNaseL |
07/25/2002 | DE10102337A1 Preparing ester containing polyunsaturated fatty acids, useful e.g. in animal or human nutrition, by transforming organism with desaturase gene from Phaeodactylum tricornatum |
07/25/2002 | DE10056059A1 Differenzierung auslösende Substanzen Differentiation-inducing substances |
07/25/2002 | CA2771117A1 Bacillus thuringiensis insecticidal proteins |
07/25/2002 | CA2440317A1 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
07/25/2002 | CA2437082A1 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
07/25/2002 | CA2435287A1 Nucleic acid delivery formulations |
07/25/2002 | CA2435260A1 Receptors and membrane-associated proteins |
07/25/2002 | CA2435180A1 A virus causing respiratory tract illness in susceptible mammals |
07/25/2002 | CA2435081A1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
07/25/2002 | CA2435037A1 Bifunctional fusion proteins with glucocerebrosidase activity |
07/25/2002 | CA2434928A1 Genes |
07/25/2002 | CA2434802A1 Isolating cells expressing secreted proteins |
07/25/2002 | CA2434696A1 P27 prevents cellular migration |
07/25/2002 | CA2434364A1 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
07/25/2002 | CA2434362A1 Pluripotent adult stem cells derived from regenerative tissue |
07/25/2002 | CA2434099A1 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
07/25/2002 | CA2433419A1 A method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same |
07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
07/25/2002 | CA2432800A1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
07/25/2002 | CA2432730A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
07/25/2002 | CA2432041A1 Polynucleotides encoding human phosphatases |
07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
07/25/2002 | CA2427643A1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
07/25/2002 | CA2330223A1 Expression cassette and plasmid for strong constitutive gene expression and the use thereof |
07/24/2002 | EP1225228A2 A method for introducing foreign matters into living cells using a laser beam |
07/24/2002 | EP1225226A1 Peptides and nucleic acid sequences related to Epstein Barr Virus |
07/24/2002 | EP1225225A2 Osteogenic devices |
07/24/2002 | EP1225221A1 Laser-based method for cell wall and membrane perforation |
07/24/2002 | EP1225220A1 Dna encoding endo-beta-galactosidase |
07/24/2002 | EP1225219A1 Method for cloning and expression of BstYI restriction endonuclease and BstYI methylase in E. coli and purification of BstYI and M.BstYI enzymes |
07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
07/24/2002 | EP1224942A1 Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases |
07/24/2002 | EP1224465A2 Detection of hla-g |
07/24/2002 | EP1224314A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
07/24/2002 | EP1224313A1 Adeno-associated viruses and uses thereof |
07/24/2002 | EP1224312A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
07/24/2002 | EP1224305A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
07/24/2002 | EP1224302A2 Modified viral surface proteins which bind to cells of tumor vasculature |
07/24/2002 | EP1224300A2 Heterologous production of polyketides |
07/24/2002 | EP1224298A1 Fibrinolytically active polypeptide |
07/24/2002 | EP1224295A1 Method and compositions for improved polynucleotide synthesis |
07/24/2002 | EP1224294A2 Mutant luciferase |
07/24/2002 | EP1224291A1 Multiple sclerosis-related superantigen |
07/24/2002 | EP1224289A1 A peroxidase genomic gene derived from ipomoea batatas and a promoter thereof |
07/24/2002 | EP1224288A2 Processed human chemokines phc-1 and phc-2 |
07/24/2002 | EP1224287A2 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r2 |
07/24/2002 | EP1224285A2 27 human secreted proteins |
07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
07/24/2002 | EP1224282A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
07/24/2002 | EP1224281A1 37 human secreted proteins |
07/24/2002 | EP1224278A1 Dna isolation method |
07/24/2002 | EP1224274A1 Tumor necrosis factor related receptor, tr6 |
07/24/2002 | EP1224271A1 Expression of recombinant mature lysostaphin |
07/24/2002 | EP1224268A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
07/24/2002 | EP1224266A2 Lysosomal targeting pathway enzymes |
07/24/2002 | EP1224265A1 Novel human potassium channel subunit |
07/24/2002 | EP1224264A2 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
07/24/2002 | EP1224263A2 Medium for preparing dedifferentiated cells |
07/24/2002 | EP1224262A2 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |
07/24/2002 | EP1224261A1 C-myc antisense-treated hematopoietic stem cell composition and method |
07/24/2002 | EP1224260A2 Methods for improving viral vector titers and reducing cell death in cell cultures |
07/24/2002 | EP1224259A1 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
07/24/2002 | EP1224222A2 Chemokine receptor |
07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |